+390677209020 | +39 0267380552 info@direnzo.biz | sedemilano@direnzo.biz | Italian Language

Biocidal Products Directive: an updated guide, what to do now

Biocidal Product Directive

Professionals still search in the internet for the biocidal products directive (Directive 98/8/EC). Today, however, the European regulatory framework is Regulation (EU) 528/2012 (BPR).

In this guide, we will clarify what the Directive provides for, what changed with the BPR, how the topic of the Italian PMC is related to it, and which are the next steps to be compliant. For a quick examination of your specific case, please contact us at  info@direnzo.biz

What was Directive 98/8/EC (BPD)

Directive 98/8/EC regulated the marketing of biocidal products in the EU, introducing a harmonised approach to the assessment of active substances and authorisation of the products.

The BPD provided for a 10-year revision plan of all active substances on the market before 14 May 2000, in order to identify and group those substances whose use is considered suitable for the preparation of biocides.

This situation implies a transition period, during which national legislations overlap with the European regulations.

The Directive key points

  • Positive lists of admitted active substances (annexes I and IA).
  • Technical and scientific evaluation shared at European level
  • Adoption in the national regulations through implementing decrees.

The new provisions of Regulation (EU) 528/2012 (BPR)

The BPR has replaced Directive 98/8/EC and it now regulates the marketing and use of biocides in the European Union. This is an essential step due to the need of developing a European legislation able to regulate adequately all those products falling into the classification of biocides , so far subject to different regulations based on the involved country.

For companies, the most relevant novelties are the following:

1) Approval of the active substances and Union List

  • The active substances are approved at EU level with specific deadlines and conditions.
  • The approved active substances are included in the Union List.

2) Authorisation of biocidal products

  • National authorisations with possible mutual recognition (in sequence or in parallel.
  • Union authorisation.
  • Duration usually up to 10 years, that can be renewed.

3) Treated articles and double function

  • Obligations also for articles/materials treated with biocides; attention to labelling specific requirements.

4) Exclusion criteria/substitution of active substance and data sharing

  • Mechanisms to reduce the use of substances raising more issues.
  • Promotion of data sharing.

5) Use of the IUCLID software

  • Preparation/management of the dossier in IUCLID with technical validation.

Do you need any support on active substances, PTs and authorisation pathways? Contact us at info@direnzo.biz to book a preliminary meeting and learn in detail about our advising services.

Italy: PMC/biocides relation

In Italy, PMC (Presidi Medico Chirurgici, Medical Surgical Aids) are an historical category regulated at national level. With the BPR entering into force, the products with active substances approved in the EU falls into the framework of biocides.

For companies, this implies:

  • A verification of the status of the active substance, product type (PT) and authorisation pathway that is more appropriate (registration as PMC, biocidal authorisation or other).
  • Transition from the PMC regime to the biocidal regime when the active substances are approved.
  • Alignment of labelling, advertising (e.g. bans of claims such as “not harmful”) and surveillance.
Ask Biocidal

An operative pathway in 6 steps (checklist)

1. Understand the legal framework of the product and map the active substances

  • Check the active substance, intended use (PT) and claims.
  • Check the approval status of the active substance based on the PT.

2. Choose the appropriate authorisation strategy

  • In the case of a biocidal product: national, mutual recognition (in sequence/in parallel) or Union authorisation.
  • In the case of a PMC: national registration.

3. Prepare the dossier

  • Draft the dossier with  software IUCLID + studies (including efficacy, toxicological and ecotoxicological studies, risk assessments) + SDS + label + etc.

4. Submit the dossier to the Competent Authorities

  • Submit the dossier via the Biocidal Product Register (R4BP3).

5. Post-marketing compliance

  • Compliant advertising (e.g. art. 72 BPR).

6. Governance and update

  • Monitoring of the regulations on biocides, authorisation renewals, variations management, vigilance/incident reporting.

FAQ – Biocidal Product Directive

Is Directive 98/8/EC still effective?

No. Regulation (EU) 528/2012 (BPR) currently applies.

What is the difference between “biocides directive” and BPR?

The Directive established common principles adopted by the Member States; the BPR is directly applicable and has introduced more harmonised tools (such as the Union authorisation, rules on treated articles, substitution criteria, data sharing).

What changes for PMC?

PMCs are a national category. When active substances are approved in the EU, the products fall into the framework of the BPR: a transition period and an authorisation pathway have to be evaluated.

What is the duration of a biocidal authorisation?

Up to 10 years (except in case of specific conditions), with possible renewals.

Can I advertise a biocide as “safe” and “non toxic”?

No. Advertising is regulated: misleading claims are forbidden and specific warnings are to be stated.

Talk to a BPR expert